EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer. (Record no. 30019218)

MARC details
000 -LEADER
fixed length control field 01646 a2200445 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250518054513.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 202004s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 1744-8301
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.2217/fon-2019-0370
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Bardia, Aditya
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 20200409
245 00 - TITLE STATEMENT
Title EMERALD: Phase III trial of elacestrant (RAD1901) vs endocrine therapy for previously treated ER+ advanced breast cancer.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Future oncology (London, England)
Date of publication, distribution, etc. Oct 2019
300 ## - PHYSICAL DESCRIPTION
Extent 3209-3218 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial Protocol; Journal Article
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antineoplastic Combined Chemotherapy Protocols
General subdivision therapeutic use
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Breast Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Estrogen Receptor alpha
General subdivision metabolism
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Follow-Up Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Fulvestrant
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element International Agencies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prognosis
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Prospective Studies
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Survival Rate
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tetrahydronaphthalenes
General subdivision administration & dosage
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Randomized Controlled Trials as Topic
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Multicenter Studies as Topic
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Aftimos, Philippe
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Bihani, Teeru
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Anderson-Villaluz, Alfred T
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jung, JungAh
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Conlan, Maureen G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Kaklamani, Virginia G
773 0# - HOST ITEM ENTRY
Title Future oncology (London, England)
Related parts vol. 15
-- no. 28
-- p. 3209-3218
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.2217/fon-2019-0370">https://doi.org/10.2217/fon-2019-0370</a>
Public note Available from publisher's website

No items available.